Anti-Infective Therapy is the infusion of antibiotic, antiviral, or antifungal drugs which are used to treat infections that do not respond to oral medications.
This report aims to provide a comprehensive presentation of the global market for Anti-Infective Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anti-Infective Therapy. This report contains market size and forecasts of Anti-Infective Therapy in global, including the following market information:
Global Anti-Infective Therapy Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Anti-Infective Therapy market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Penicillin Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Anti-Infective Therapy include Abbott Laboratories Ltd., Cipla Ltd., Athanas Enterprise Private Limited(Claris Lifesciences Limited (Claris)), Glenmark Pharmaceuticals Limited, GlaxoSmithKline plc.(GlaxoSmithKline Pharmaceuticals Ltd), Lupin Limited, Panacea Biotec Limited, Novartis AG and Pfizer, Inc., etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Anti-Infective Therapy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Anti-Infective Therapy Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Anti-Infective Therapy Market Segment Percentages, by Type, 2022 (%)
Penicillin
Sulphonamides
Aminoglycosides
Fluoroquinolones
Antifungals
Antiprotozoal
Others
Global Anti-Infective Therapy Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Anti-Infective Therapy Market Segment Percentages, by Application, 2022 (%)
Home User
Hospitals/Clinics
Ambulatory Surgery Centres
Others
Global Anti-Infective Therapy Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Anti-Infective Therapy Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Anti-Infective Therapy revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Anti-Infective Therapy revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Abbott Laboratories Ltd.
Cipla Ltd.
Athanas Enterprise Private Limited(Claris Lifesciences Limited (Claris))
Glenmark Pharmaceuticals Limited
GlaxoSmithKline plc.(GlaxoSmithKline Pharmaceuticals Ltd)
Lupin Limited
Panacea Biotec Limited
Novartis AG
Pfizer, Inc.
Ranbaxy Laboratories Limited
Sun Pharmaceutical Industries Limited
AstraZeneca plc
Johnson & Johnson
WOCKHARDT
F. Hoffmann-La Roche Ltd
Sanofi
Merck
Outline of Major Chapters:
Chapter 1: Introduces the definition of Anti-Infective Therapy, market overview.
Chapter 2: Global Anti-Infective Therapy market size in revenue.
Chapter 3: Detailed analysis of Anti-Infective Therapy company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Anti-Infective Therapy in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Anti-Infective Therapy Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Anti-Infective Therapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Anti-Infective Therapy Overall Market Size
2.1 Global Anti-Infective Therapy Market Size: 2022 VS 2029
2.2 Global Anti-Infective Therapy Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Anti-Infective Therapy Players in Global Market
3.2 Top Global Anti-Infective Therapy Companies Ranked by Revenue
3.3 Global Anti-Infective Therapy Revenue by Companies
3.4 Top 3 and Top 5 Anti-Infective Therapy Companies in Global Market, by Revenue in 2022
3.5 Global Companies Anti-Infective Therapy Product Type
3.6 Tier 1, Tier 2 and Tier 3 Anti-Infective Therapy Players in Global Market
3.6.1 List of Global Tier 1 Anti-Infective Therapy Companies
3.6.2 List of Global Tier 2 and Tier 3 Anti-Infective Therapy Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Anti-Infective Therapy Market Size Markets, 2022 & 2029
4.1.2 Penicillin
4.1.3 Sulphonamides
4.1.4 Aminoglycosides
4.1.5 Fluoroquinolones
4.1.6 Antifungals
4.1.7 Antiprotozoal
4.1.8 Others
4.2 By Type - Global Anti-Infective Therapy Revenue & Forecasts
4.2.1 By Type - Global Anti-Infective Therapy Revenue, 2018-2023
4.2.2 By Type - Global Anti-Infective Therapy Revenue, 2024-2029
4.2.3 By Type - Global Anti-Infective Therapy Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Anti-Infective Therapy Market Size, 2022 & 2029
5.1.2 Home User
5.1.3 Hospitals/Clinics
5.1.4 Ambulatory Surgery Centres
5.1.5 Others
5.2 By Application - Global Anti-Infective Therapy Revenue & Forecasts
5.2.1 By Application - Global Anti-Infective Therapy Revenue, 2018-2023
5.2.2 By Application - Global Anti-Infective Therapy Revenue, 2024-2029
5.2.3 By Application - Global Anti-Infective Therapy Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Anti-Infective Therapy Market Size, 2022 & 2029
6.2 By Region - Global Anti-Infective Therapy Revenue & Forecasts
6.2.1 By Region - Global Anti-Infective Therapy Revenue, 2018-2023
6.2.2 By Region - Global Anti-Infective Therapy Revenue, 2024-2029
6.2.3 By Region - Global Anti-Infective Therapy Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Anti-Infective Therapy Revenue, 2018-2029
6.3.2 US Anti-Infective Therapy Market Size, 2018-2029
6.3.3 Canada Anti-Infective Therapy Market Size, 2018-2029
6.3.4 Mexico Anti-Infective Therapy Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Anti-Infective Therapy Revenue, 2018-2029
6.4.2 Germany Anti-Infective Therapy Market Size, 2018-2029
6.4.3 France Anti-Infective Therapy Market Size, 2018-2029
6.4.4 U.K. Anti-Infective Therapy Market Size, 2018-2029
6.4.5 Italy Anti-Infective Therapy Market Size, 2018-2029
6.4.6 Russia Anti-Infective Therapy Market Size, 2018-2029
6.4.7 Nordic Countries Anti-Infective Therapy Market Size, 2018-2029
6.4.8 Benelux Anti-Infective Therapy Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Anti-Infective Therapy Revenue, 2018-2029
6.5.2 China Anti-Infective Therapy Market Size, 2018-2029
6.5.3 Japan Anti-Infective Therapy Market Size, 2018-2029
6.5.4 South Korea Anti-Infective Therapy Market Size, 2018-2029
6.5.5 Southeast Asia Anti-Infective Therapy Market Size, 2018-2029
6.5.6 India Anti-Infective Therapy Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Anti-Infective Therapy Revenue, 2018-2029
6.6.2 Brazil Anti-Infective Therapy Market Size, 2018-2029
6.6.3 Argentina Anti-Infective Therapy Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Anti-Infective Therapy Revenue, 2018-2029
6.7.2 Turkey Anti-Infective Therapy Market Size, 2018-2029
6.7.3 Israel Anti-Infective Therapy Market Size, 2018-2029
6.7.4 Saudi Arabia Anti-Infective Therapy Market Size, 2018-2029
6.7.5 UAE Anti-Infective Therapy Market Size, 2018-2029
7 Anti-Infective Therapy Companies Profiles
7.1 Abbott Laboratories Ltd.
7.1.1 Abbott Laboratories Ltd. Company Summary
7.1.2 Abbott Laboratories Ltd. Business Overview
7.1.3 Abbott Laboratories Ltd. Anti-Infective Therapy Major Product Offerings
7.1.4 Abbott Laboratories Ltd. Anti-Infective Therapy Revenue in Global Market (2018-2023)
7.1.5 Abbott Laboratories Ltd. Key News & Latest Developments
7.2 Cipla Ltd.
7.2.1 Cipla Ltd. Company Summary
7.2.2 Cipla Ltd. Business Overview
7.2.3 Cipla Ltd. Anti-Infective Therapy Major Product Offerings
7.2.4 Cipla Ltd. Anti-Infective Therapy Revenue in Global Market (2018-2023)
7.2.5 Cipla Ltd. Key News & Latest Developments
7.3 Athanas Enterprise Private Limited(Claris Lifesciences Limited (Claris))
7.3.1 Athanas Enterprise Private Limited(Claris Lifesciences Limited (Claris)) Company Summary
7.3.2 Athanas Enterprise Private Limited(Claris Lifesciences Limited (Claris)) Business Overview
7.3.3 Athanas Enterprise Private Limited(Claris Lifesciences Limited (Claris)) Anti-Infective Therapy Major Product Offerings
7.3.4 Athanas Enterprise Private Limited(Claris Lifesciences Limited (Claris)) Anti-Infective Therapy Revenue in Global Market (2018-2023)
7.3.5 Athanas Enterprise Private Limited(Claris Lifesciences Limited (Claris)) Key News & Latest Developments
7.4 Glenmark Pharmaceuticals Limited
7.4.1 Glenmark Pharmaceuticals Limited Company Summary
7.4.2 Glenmark Pharmaceuticals Limited Business Overview
7.4.3 Glenmark Pharmaceuticals Limited Anti-Infective Therapy Major Product Offerings
7.4.4 Glenmark Pharmaceuticals Limited Anti-Infective Therapy Revenue in Global Market (2018-2023)
7.4.5 Glenmark Pharmaceuticals Limited Key News & Latest Developments
7.5 GlaxoSmithKline plc.(GlaxoSmithKline Pharmaceuticals Ltd)
7.5.1 GlaxoSmithKline plc.(GlaxoSmithKline Pharmaceuticals Ltd) Company Summary
7.5.2 GlaxoSmithKline plc.(GlaxoSmithKline Pharmaceuticals Ltd) Business Overview
7.5.3 GlaxoSmithKline plc.(GlaxoSmithKline Pharmaceuticals Ltd) Anti-Infective Therapy Major Product Offerings
7.5.4 GlaxoSmithKline plc.(GlaxoSmithKline Pharmaceuticals Ltd) Anti-Infective Therapy Revenue in Global Market (2018-2023)
7.5.5 GlaxoSmithKline plc.(GlaxoSmithKline Pharmaceuticals Ltd) Key News & Latest Developments
7.6 Lupin Limited
7.6.1 Lupin Limited Company Summary
7.6.2 Lupin Limited Business Overview
7.6.3 Lupin Limited Anti-Infective Therapy Major Product Offerings
7.6.4 Lupin Limited Anti-Infective Therapy Revenue in Global Market (2018-2023)
7.6.5 Lupin Limited Key News & Latest Developments
7.7 Panacea Biotec Limited
7.7.1 Panacea Biotec Limited Company Summary
7.7.2 Panacea Biotec Limited Business Overview
7.7.3 Panacea Biotec Limited Anti-Infective Therapy Major Product Offerings
7.7.4 Panacea Biotec Limited Anti-Infective Therapy Revenue in Global Market (2018-2023)
7.7.5 Panacea Biotec Limited Key News & Latest Developments
7.8 Novartis AG
7.8.1 Novartis AG Company Summary
7.8.2 Novartis AG Business Overview
7.8.3 Novartis AG Anti-Infective Therapy Major Product Offerings
7.8.4 Novartis AG Anti-Infective Therapy Revenue in Global Market (2018-2023)
7.8.5 Novartis AG Key News & Latest Developments
7.9 Pfizer, Inc.
7.9.1 Pfizer, Inc. Company Summary
7.9.2 Pfizer, Inc. Business Overview
7.9.3 Pfizer, Inc. Anti-Infective Therapy Major Product Offerings
7.9.4 Pfizer, Inc. Anti-Infective Therapy Revenue in Global Market (2018-2023)
7.9.5 Pfizer, Inc. Key News & Latest Developments
7.10 Ranbaxy Laboratories Limited
7.10.1 Ranbaxy Laboratories Limited Company Summary
7.10.2 Ranbaxy Laboratories Limited Business Overview
7.10.3 Ranbaxy Laboratories Limited Anti-Infective Therapy Major Product Offerings
7.10.4 Ranbaxy Laboratories Limited Anti-Infective Therapy Revenue in Global Market (2018-2023)
7.10.5 Ranbaxy Laboratories Limited Key News & Latest Developments
7.11 Sun Pharmaceutical Industries Limited
7.11.1 Sun Pharmaceutical Industries Limited Company Summary
7.11.2 Sun Pharmaceutical Industries Limited Business Overview
7.11.3 Sun Pharmaceutical Industries Limited Anti-Infective Therapy Major Product Offerings
7.11.4 Sun Pharmaceutical Industries Limited Anti-Infective Therapy Revenue in Global Market (2018-2023)
7.11.5 Sun Pharmaceutical Industries Limited Key News & Latest Developments
7.12 AstraZeneca plc
7.12.1 AstraZeneca plc Company Summary
7.12.2 AstraZeneca plc Business Overview
7.12.3 AstraZeneca plc Anti-Infective Therapy Major Product Offerings
7.12.4 AstraZeneca plc Anti-Infective Therapy Revenue in Global Market (2018-2023)
7.12.5 AstraZeneca plc Key News & Latest Developments
7.13 Johnson & Johnson
7.13.1 Johnson & Johnson Company Summary
7.13.2 Johnson & Johnson Business Overview
7.13.3 Johnson & Johnson Anti-Infective Therapy Major Product Offerings
7.13.4 Johnson & Johnson Anti-Infective Therapy Revenue in Global Market (2018-2023)
7.13.5 Johnson & Johnson Key News & Latest Developments
7.14 WOCKHARDT
7.14.1 WOCKHARDT Company Summary
7.14.2 WOCKHARDT Business Overview
7.14.3 WOCKHARDT Anti-Infective Therapy Major Product Offerings
7.14.4 WOCKHARDT Anti-Infective Therapy Revenue in Global Market (2018-2023)
7.14.5 WOCKHARDT Key News & Latest Developments
7.15 F. Hoffmann-La Roche Ltd
7.15.1 F. Hoffmann-La Roche Ltd Company Summary
7.15.2 F. Hoffmann-La Roche Ltd Business Overview
7.15.3 F. Hoffmann-La Roche Ltd Anti-Infective Therapy Major Product Offerings
7.15.4 F. Hoffmann-La Roche Ltd Anti-Infective Therapy Revenue in Global Market (2018-2023)
7.15.5 F. Hoffmann-La Roche Ltd Key News & Latest Developments
7.16 Sanofi
7.16.1 Sanofi Company Summary
7.16.2 Sanofi Business Overview
7.16.3 Sanofi Anti-Infective Therapy Major Product Offerings
7.16.4 Sanofi Anti-Infective Therapy Revenue in Global Market (2018-2023)
7.16.5 Sanofi Key News & Latest Developments
7.17 Merck
7.17.1 Merck Company Summary
7.17.2 Merck Business Overview
7.17.3 Merck Anti-Infective Therapy Major Product Offerings
7.17.4 Merck Anti-Infective Therapy Revenue in Global Market (2018-2023)
7.17.5 Merck Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Anti-Infective Therapy Market Opportunities & Trends in Global Market
Table 2. Anti-Infective Therapy Market Drivers in Global Market
Table 3. Anti-Infective Therapy Market Restraints in Global Market
Table 4. Key Players of Anti-Infective Therapy in Global Market
Table 5. Top Anti-Infective Therapy Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Anti-Infective Therapy Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Anti-Infective Therapy Revenue Share by Companies, 2018-2023
Table 8. Global Companies Anti-Infective Therapy Product Type
Table 9. List of Global Tier 1 Anti-Infective Therapy Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Anti-Infective Therapy Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Anti-Infective Therapy Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Anti-Infective Therapy Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Anti-Infective Therapy Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Anti-Infective Therapy Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Anti-Infective Therapy Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Anti-Infective Therapy Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Anti-Infective Therapy Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Anti-Infective Therapy Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Anti-Infective Therapy Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Anti-Infective Therapy Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Anti-Infective Therapy Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Anti-Infective Therapy Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Anti-Infective Therapy Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Anti-Infective Therapy Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Anti-Infective Therapy Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Anti-Infective Therapy Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Anti-Infective Therapy Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Anti-Infective Therapy Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Anti-Infective Therapy Revenue, (US$, Mn), 2024-2029
Table 30. Abbott Laboratories Ltd. Company Summary
Table 31. Abbott Laboratories Ltd. Anti-Infective Therapy Product Offerings
Table 32. Abbott Laboratories Ltd. Anti-Infective Therapy Revenue (US$, Mn) & (2018-2023)
Table 33. Abbott Laboratories Ltd. Key News & Latest Developments
Table 34. Cipla Ltd. Company Summary
Table 35. Cipla Ltd. Anti-Infective Therapy Product Offerings
Table 36. Cipla Ltd. Anti-Infective Therapy Revenue (US$, Mn) & (2018-2023)
Table 37. Cipla Ltd. Key News & Latest Developments
Table 38. Athanas Enterprise Private Limited(Claris Lifesciences Limited (Claris)) Company Summary
Table 39. Athanas Enterprise Private Limited(Claris Lifesciences Limited (Claris)) Anti-Infective Therapy Product Offerings
Table 40. Athanas Enterprise Private Limited(Claris Lifesciences Limited (Claris)) Anti-Infective Therapy Revenue (US$, Mn) & (2018-2023)
Table 41. Athanas Enterprise Private Limited(Claris Lifesciences Limited (Claris)) Key News & Latest Developments
Table 42. Glenmark Pharmaceuticals Limited Company Summary
Table 43. Glenmark Pharmaceuticals Limited Anti-Infective Therapy Product Offerings
Table 44. Glenmark Pharmaceuticals Limited Anti-Infective Therapy Revenue (US$, Mn) & (2018-2023)
Table 45. Glenmark Pharmaceuticals Limited Key News & Latest Developments
Table 46. GlaxoSmithKline plc.(GlaxoSmithKline Pharmaceuticals Ltd) Company Summary
Table 47. GlaxoSmithKline plc.(GlaxoSmithKline Pharmaceuticals Ltd) Anti-Infective Therapy Product Offerings
Table 48. GlaxoSmithKline plc.(GlaxoSmithKline Pharmaceuticals Ltd) Anti-Infective Therapy Revenue (US$, Mn) & (2018-2023)
Table 49. GlaxoSmithKline plc.(GlaxoSmithKline Pharmaceuticals Ltd) Key News & Latest Developments
Table 50. Lupin Limited Company Summary
Table 51. Lupin Limited Anti-Infective Therapy Product Offerings
Table 52. Lupin Limited Anti-Infective Therapy Revenue (US$, Mn) & (2018-2023)
Table 53. Lupin Limited Key News & Latest Developments
Table 54. Panacea Biotec Limited Company Summary
Table 55. Panacea Biotec Limited Anti-Infective Therapy Product Offerings
Table 56. Panacea Biotec Limited Anti-Infective Therapy Revenue (US$, Mn) & (2018-2023)
Table 57. Panacea Biotec Limited Key News & Latest Developments
Table 58. Novartis AG Company Summary
Table 59. Novartis AG Anti-Infective Therapy Product Offerings
Table 60. Novartis AG Anti-Infective Therapy Revenue (US$, Mn) & (2018-2023)
Table 61. Novartis AG Key News & Latest Developments
Table 62. Pfizer, Inc. Company Summary
Table 63. Pfizer, Inc. Anti-Infective Therapy Product Offerings
Table 64. Pfizer, Inc. Anti-Infective Therapy Revenue (US$, Mn) & (2018-2023)
Table 65. Pfizer, Inc. Key News & Latest Developments
Table 66. Ranbaxy Laboratories Limited Company Summary
Table 67. Ranbaxy Laboratories Limited Anti-Infective Therapy Product Offerings
Table 68. Ranbaxy Laboratories Limited Anti-Infective Therapy Revenue (US$, Mn) & (2018-2023)
Table 69. Ranbaxy Laboratories Limited Key News & Latest Developments
Table 70. Sun Pharmaceutical Industries Limited Company Summary
Table 71. Sun Pharmaceutical Industries Limited Anti-Infective Therapy Product Offerings
Table 72. Sun Pharmaceutical Industries Limited Anti-Infective Therapy Revenue (US$, Mn) & (2018-2023)
Table 73. Sun Pharmaceutical Industries Limited Key News & Latest Developments
Table 74. AstraZeneca plc Company Summary
Table 75. AstraZeneca plc Anti-Infective Therapy Product Offerings
Table 76. AstraZeneca plc Anti-Infective Therapy Revenue (US$, Mn) & (2018-2023)
Table 77. AstraZeneca plc Key News & Latest Developments
Table 78. Johnson & Johnson Company Summary
Table 79. Johnson & Johnson Anti-Infective Therapy Product Offerings
Table 80. Johnson & Johnson Anti-Infective Therapy Revenue (US$, Mn) & (2018-2023)
Table 81. Johnson & Johnson Key News & Latest Developments
Table 82. WOCKHARDT Company Summary
Table 83. WOCKHARDT Anti-Infective Therapy Product Offerings
Table 84. WOCKHARDT Anti-Infective Therapy Revenue (US$, Mn) & (2018-2023)
Table 85. WOCKHARDT Key News & Latest Developments
Table 86. F. Hoffmann-La Roche Ltd Company Summary
Table 87. F. Hoffmann-La Roche Ltd Anti-Infective Therapy Product Offerings
Table 88. F. Hoffmann-La Roche Ltd Anti-Infective Therapy Revenue (US$, Mn) & (2018-2023)
Table 89. F. Hoffmann-La Roche Ltd Key News & Latest Developments
Table 90. Sanofi Company Summary
Table 91. Sanofi Anti-Infective Therapy Product Offerings
Table 92. Sanofi Anti-Infective Therapy Revenue (US$, Mn) & (2018-2023)
Table 93. Sanofi Key News & Latest Developments
Table 94. Merck Company Summary
Table 95. Merck Anti-Infective Therapy Product Offerings
Table 96. Merck Anti-Infective Therapy Revenue (US$, Mn) & (2018-2023)
Table 97. Merck Key News & Latest Developments
List of Figures
Figure 1. Anti-Infective Therapy Segment by Type in 2022
Figure 2. Anti-Infective Therapy Segment by Application in 2022
Figure 3. Global Anti-Infective Therapy Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Anti-Infective Therapy Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Anti-Infective Therapy Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Anti-Infective Therapy Revenue in 2022
Figure 8. By Type - Global Anti-Infective Therapy Revenue Market Share, 2018-2029
Figure 9. By Application - Global Anti-Infective Therapy Revenue Market Share, 2018-2029
Figure 10. By Type - Global Anti-Infective Therapy Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Anti-Infective Therapy Revenue Market Share, 2018-2029
Figure 12. By Application - Global Anti-Infective Therapy Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Anti-Infective Therapy Revenue Market Share, 2018-2029
Figure 14. By Region - Global Anti-Infective Therapy Revenue Market Share, 2018-2029
Figure 15. By Country - North America Anti-Infective Therapy Revenue Market Share, 2018-2029
Figure 16. US Anti-Infective Therapy Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Anti-Infective Therapy Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Anti-Infective Therapy Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Anti-Infective Therapy Revenue Market Share, 2018-2029
Figure 20. Germany Anti-Infective Therapy Revenue, (US$, Mn), 2018-2029
Figure 21. France Anti-Infective Therapy Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Anti-Infective Therapy Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Anti-Infective Therapy Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Anti-Infective Therapy Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Anti-Infective Therapy Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Anti-Infective Therapy Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Anti-Infective Therapy Revenue Market Share, 2018-2029
Figure 28. China Anti-Infective Therapy Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Anti-Infective Therapy Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Anti-Infective Therapy Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Anti-Infective Therapy Revenue, (US$, Mn), 2018-2029
Figure 32. India Anti-Infective Therapy Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Anti-Infective Therapy Revenue Market Share, 2018-2029
Figure 34. Brazil Anti-Infective Therapy Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Anti-Infective Therapy Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Anti-Infective Therapy Revenue Market Share, 2018-2029
Figure 37. Turkey Anti-Infective Therapy Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Anti-Infective Therapy Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Anti-Infective Therapy Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Anti-Infective Therapy Revenue, (US$, Mn), 2018-2029
Figure 41. Abbott Laboratories Ltd. Anti-Infective Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Cipla Ltd. Anti-Infective Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Athanas Enterprise Private Limited(Claris Lifesciences Limited (Claris)) Anti-Infective Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Glenmark Pharmaceuticals Limited Anti-Infective Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. GlaxoSmithKline plc.(GlaxoSmithKline Pharmaceuticals Ltd) Anti-Infective Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Lupin Limited Anti-Infective Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Panacea Biotec Limited Anti-Infective Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Novartis AG Anti-Infective Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Pfizer, Inc. Anti-Infective Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Ranbaxy Laboratories Limited Anti-Infective Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Sun Pharmaceutical Industries Limited Anti-Infective Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. AstraZeneca plc Anti-Infective Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. Johnson & Johnson Anti-Infective Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 54. WOCKHARDT Anti-Infective Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 55. F. Hoffmann-La Roche Ltd Anti-Infective Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 56. Sanofi Anti-Infective Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 57. Merck Anti-Infective Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
